Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
---|---|---|---|---|---|---|---|---|
INCY | INCYTE CORP | United States | $12.82B | 224,526,128 | 79.30% | 20.70% | Net Selling | Net Buying |
SMLR | SEMLER SCIENTIFIC INC | United States | $200.74M | 7,031,083 | 40.20% | 59.80% | Net Buying | |
NBIX | NEUROCRINE BIOSCIENCES INC | United States | $13.72B | 99,507,490 | 69.67% | 30.33% | Net Selling | Net Selling |
HRMY | HARMONY BIOSCIENCES HOLDINGS INC | United States | $1.90B | 56,769,081 | 61.02% | 38.98% | Net Selling | Net Buying |
VYGR | VOYAGER THERAPEUTICS INC | United States | $519.11M | 54,300,627 | 47.22% | 52.78% | Net Selling | Net Selling |
INMD | INMODE LTD | Israel | $1.78B | 83,982,462 | 62.26% | 0.00% | ||
BMY | BRISTOL MYERS SQUIBB CO | United States | $107.68B | 2,022,193,411 | 76.46% | 0.36% | Net Selling | Net Selling |
PGNY | PROGYNY INC | United States | $3.67B | 96,499,402 | 73.53% | 26.47% | Net Selling | Net Selling |
AMLX | AMYLYX PHARMACEUTICALS INC | United States | $195.21M | 67,782,139 | 52.71% | 47.29% | Net Buying | Net Selling |
RPRX | ROYALTY PHARMA PLC | United States | $18.19B | 597,434,791 | 51.02% | 16.51% | Net Selling | Net Selling |
SDGR | SCHRODINGER INC | United States | $1.93B | 72,310,612 | 77.41% | 22.59% | Net Selling | Net Selling |
CNC | CENTENE CORP | United States | $41.91B | 534,863,000 | 93.63% | 3.10% | Net Selling | Net Selling |
KMDA | KAMADA LTD | Israel | $321.89M | 57,479,528 | 10.06% | 0.00% | ||
UTHR | UNITED THERAPEUTICS CORP | United States | $11.45B | 47,058,545 | 87.59% | 12.41% | Net Selling | Net Selling |
JNJ | JOHNSON & JOHNSON | United States | $380.49B | 2,408,767,228 | 69.52% | 0.19% | Net Selling | Net Selling |
OSUR | ORASURE TECHNOLOGIES INC | United States | $453.11M | 73,796,268 | 91.60% | 8.40% | Net Selling | Net Selling |
DCGO | DOCGO INC | United States | $422.94M | 104,171,369 | 55.45% | 21.45% | Net Selling | Net Buying |
LNTH | LANTHEUS HOLDINGS INC | United States | $4.14B | 68,525,556 | 53.57% | 46.43% | Net Selling | Net Selling |
AMPH | AMPHASTAR PHARMACEUTICALS INC | United States | $2.09B | 48,095,862 | 49.07% | 50.93% | Net Selling | Net Selling |
EXEL | EXELIXIS INC | United States | $7.23B | 303,194,259 | 85.27% | 4.07% | Net Selling | Net Buying |
AZN | ASTRAZENECA PLC | United Kingdom | $211.63B | 1,550,162,626 | 31.49% | 0.00% | ||
PBYI | PUMA BIOTECHNOLOGY INC | United States | $269.00M | 48,207,162 | 55.20% | 44.43% | Net Selling | Net Selling |
SLP | SIMULATIONS PLUS INC | United States | $825.64M | 19,967,077 | 58.53% | 41.47% | Net Selling | Net Selling |
STAA | STAAR SURGICAL CO | United States | $1.84B | 48,865,875 | 63.00% | 37.00% | Net Buying | Net Buying |
PCRX | PACIRA BIOSCIENCES INC | United States | $1.35B | 46,500,778 | 68.56% | 31.44% | Net Selling | Net Selling |
HALO | HALOZYME THERAPEUTICS INC | United States | $5.17B | 126,824,800 | 78.23% | 21.77% | Net Selling | Net Selling |
TCMD | TACTILE SYSTEMS TECHNOLOGY INC | United States | $374.31M | 23,600,584 | 76.27% | 23.73% | Net Selling | Net Selling |
HCM | HUTCHMED (CHINA) LTD | Hong Kong | $2.94B | 871,256,270 | 1.76% | 0.00% | ||
HUM | HUMANA INC | United States | $42.17B | 120,653,315 | 91.95% | 2.17% | Net Selling | Net Selling |
MDT | MEDTRONIC PLC | Ireland | $115.41B | 1,327,822,539 | 82.10% | 0.53% | Net Selling | Net Selling |
SEM | SELECT MEDICAL HOLDINGS CORP | United States | $3.78B | 128,361,492 | 7.34% | 92.66% | Net Selling | Net Selling |
CCRN | CROSS COUNTRY HEALTHCARE INC | United States | $639.99M | 34,725,677 | 83.83% | 16.17% | Net Selling | Net Selling |
CVS | CVS HEALTH CORP | United States | $99.96B | 1,258,449,553 | 80.69% | 0.63% | Net Selling | Net Selling |
EW | EDWARDS LIFESCIENCES CORP | United States | $57.19B | 601,000,000 | 79.55% | 1.16% | Net Selling | Net Buying |
CHE | CHEMED CORP | United States | $9.74B | 15,117,093 | 95.25% | 4.12% | Net Selling | Net Buying |
GILD | GILEAD SCIENCES INC | United States | $90.95B | 1,245,774,616 | 83.54% | 1.09% | Net Selling | Net Selling |
NSYS | NORTECH SYSTEMS INC | United States | $36.20M | 2,740,178 | 1.76% | 98.24% | Net Buying | |
COR | CENCORA INC | United States | $48.80B | 199,481,993 | 80.48% | 19.52% | Net Selling | Net Selling |
BNOX | BIONOMICS LIMITED | Australia | $11.90M | 1,924,808,444 | 0.07% | 0.00% | ||
CI | CIGNA GROUP | United States | $106.22B | 292,355,022 | 87.03% | 1.49% | Net Selling | Net Selling |
SIGA | SIGA TECHNOLOGIES INC | United States | $604.28M | 71,091,616 | 35.56% | 64.44% | Net Selling | Net Selling |
OPCH | OPTION CARE HEALTH INC | United States | $5.76B | 173,498,090 | 12.08% | 87.92% | Net Selling | Net Selling |
ADUS | ADDUS HOMECARE CORP | United States | $1.68B | 16,227,251 | 33.44% | 66.56% | Net Selling | Net Selling |
BMRN | BIOMARIN PHARMACEUTICAL INC | United States | $16.72B | 188,675,622 | 98.08% | 1.64% | Net Selling | Net Selling |
AMN | AMN HEALTHCARE SERVICES INC | United States | $2.33B | 37,888,539 | 91.06% | 8.94% | Net Selling | Net Buying |
CORT | CORCEPT THERAPEUTICS INC | United States | $2.62B | 103,517,388 | 30.65% | 69.35% | Net Buying | Net Buying |
ISRG | INTUITIVE SURGICAL INC | United States | $140.97B | 352,325,863 | 84.05% | 0.81% | Net Buying | Net Buying |
CAH | CARDINAL HEALTH INC | United States | $27.37B | 243,233,153 | 87.14% | 4.07% | Net Selling | Net Selling |
MDXG | MIMEDX GROUP INC | United States | $1.12B | 146,958,420 | 42.42% | 57.58% | Net Buying | Net Selling |
GMAB | GENMAB A | Denmark | $20.24B | 66,074,535 | 70.53% | 0.00% | ||
IRMD | IRADIMED CORP | United States | $549.19M | 12,662,809 | 51.01% | 41.22% | Net Selling | |
VEEV | VEEVA SYSTEMS INC | United States | $37.65B | 161,316,597 | 78.97% | 11.64% | Net Selling | Net Selling |
VMD | VIEMED HEALTHCARE INC | United States | $363.54M | 38,756,636 | 59.68% | 12.53% | Net Selling | Net Selling |
TGTX | TG THERAPEUTICS INC | United States | $2.40B | 154,420,772 | 53.78% | 46.22% | Net Selling | Net Selling |
MEIP | MEI PHARMA INC | United States | $26.12M | 6,662,857 | 17.90% | 82.10% | Net Buying | |
ALGN | ALIGN TECHNOLOGY INC | United States | $24.63B | 75,104,132 | 84.67% | 15.33% | Net Selling | Net Selling |
VNDA | VANDA PHARMACEUTICALS INC | United States | $223.82M | 57,537,499 | 56.23% | 43.77% | Net Selling | Net Selling |
DXCM | DEXCOM INC | United States | $53.77B | 385,515,421 | 95.52% | 4.48% | Net Selling | Net Selling |
MMSI | MERIT MEDICAL SYSTEMS INC | United States | $4.37B | 57,930,050 | 94.92% | 5.08% | Net Buying | Net Selling |
SNY | SANOFI | France | $125.32B | 1,264,799,969 | 19.51% | 0.00% | ||
ROIV | ROIVANT SCIENCES LTD | Bermuda | $8.74B | 805,846,006 | 40.20% | 59.80% | Net Selling | Net Selling |
FBIO | FORTRESS BIOTECH INC | United States | $19.41M | 8,942,751 | 27.98% | 72.02% | Net Buying | Net Buying |
HSIC | HENRY SCHEIN INC | United States | $9.66B | 128,505,719 | 96.06% | 3.94% | Net Selling | Net Selling |
ALC | ALCON INC | United States | $41.08B | 493,244,479 | 47.85% | 0.00% | ||
LMAT | LEMAITRE VASCULAR INC | United States | $1.50B | 22,337,216 | 73.96% | 26.04% | Net Selling | Net Selling |
PODD | INSULET CORP | United States | $11.83B | 69,925,730 | 80.09% | 19.91% | Net Selling | Net Selling |
TALK | TALKSPACE INC | United States | $602.99M | 168,903,571 | 48.64% | 32.29% | Net Buying | Net Selling |
MOH | MOLINA HEALTHCARE INC | United States | $24.45B | 58,400,000 | 79.70% | 20.30% | Net Buying | Net Buying |
THC | TENET HEALTHCARE CORP | United States | $10.49B | 99,995,000 | 34.36% | 65.64% | Net Selling | Net Selling |
ABT | ABBOTT LABORATORIES | United States | $196.91B | 1,735,184,289 | 75.12% | 1.14% | Net Selling | Net Selling |
BRKR | BRUKER CORP | United States | $12.92B | 137,671,143 | 49.25% | 50.75% | Net Selling | Net Selling |
GSK | GSK PLC | United Kingdom | $87.18B | 4,056,000,000 | 7.26% | 0.00% | ||
ZBH | ZIMMER BIOMET HOLDINGS INC | United States | $27.20B | 205,084,022 | 74.93% | 25.07% | Net Selling | Net Selling |
UNH | UNITEDHEALTH GROUP INC | United States | $454.61B | 921,934,109 | 87.84% | 2.02% | Net Selling | Net Selling |
GMED | GLOBUS MEDICAL INC | United States | $7.18B | 135,372,391 | 77.48% | 22.52% | Net Selling | Net Selling |
WST | WEST PHARMACEUTICAL SERVICES INC | United States | $28.89B | 73,299,296 | 93.75% | 3.64% | Net Buying | Net Buying |
ATRC | ATRICURE INC | United States | $1.43B | 47,587,966 | 75.23% | 24.77% | Net Selling | Net Selling |
HOLX | HOLOGIC INC | United States | $18.16B | 234,731,521 | 86.75% | 13.25% | Net Selling | Net Selling |
KIDS | ORTHOPEDIATRICS CORP | United States | $682.23M | 23,549,496 | 43.14% | 56.86% | Net Selling | Net Selling |
SCYX | SCYNEXIS INC | United States | $53.02M | 37,207,799 | 44.39% | 22.02% | Net Selling | Net Selling |
PEN | PENUMBRA INC | United States | $8.76B | 38,703,659 | 88.87% | 11.05% | Net Selling | Net Selling |
ASTH | ASTRANA HEALTH INC | United States | $2.28B | 55,423,408 | 14.42% | 85.58% | Net Selling | |
UTMD | UTAH MEDICAL PRODUCTS INC | United States | $251.88M | 3,589,014 | 64.94% | 35.06% | Net Selling | |
NVS | NOVARTIS AG | Switzerland | $195.98B | 2,044,033,986 | 6.92% | 0.00% | ||
BNTX | BIONTECH SE | Germany | $22.10B | 237,725,735 | 17.05% | 0.00% | ||
FONR | FONAR CORP | United States | $146.23M | 6,710,807 | 47.70% | 3.51% | ||
COLL | COLLEGIUM PHARMACEUTICAL INC | United States | $1.31B | 31,959,828 | 58.62% | 41.38% | Net Selling | Net Selling |
ENSG | ENSIGN GROUP INC | United States | $7.12B | 56,665,741 | 60.08% | 39.92% | Net Selling | Net Selling |
ICLR | ICON PLC | Ireland | $27.18B | 82,495,086 | 95.64% | 0.00% | ||
TFX | TELEFLEX INC | United States | $10.53B | 47,056,482 | 95.84% | 2.71% | Net Selling | Net Selling |
IDXX | IDEXX LABORATORIES INC | United States | $44.83B | 83,089,381 | 87.71% | 1.68% | Net Selling | Net Selling |
BTMD | BIOTE CORP | United States | $437.50M | 74,531,558 | 17.03% | 44.56% | Net Selling | |
ZTS | ZOETIS INC | United States | $77.16B | 457,867,115 | 92.81% | 5.62% | Net Selling | Net Selling |
STRR | STAR EQUITY HOLDINGS INC | United States | $14.18M | 15,848,202 | 3.66% | 96.34% | Net Buying | Net Selling |
PLX | PROTALIX BIOTHERAPEUTICS INC | Israel | $91.32M | 73,052,124 | 6.76% | 93.24% | Net Buying | |
PINC | PREMIER INC | United States | $2.61B | 119,817,876 | 74.36% | 2.23% | Net Selling | |
DBVT | DBV TECHNOLOGIES SA | France | $147.93M | 96,431,770 | 39.10% | 15.37% | Net Buying | Net Buying |
DVA | DAVITA INC | United States | $12.00B | 87,700,000 | 14.23% | 85.77% | Net Buying | Net Buying |
RVTY | REVVITY INC | United States | $13.02B | 123,529,821 | 86.51% | 2.53% | Net Buying | Net Buying |
QTRX | QUANTERIX CORP | United States | $872.80M | 38,063,618 | 63.62% | 36.38% | Net Buying | Net Selling |
Industry | Stocks | 1d % | 1w % | 1m % | 1y % | Zen Score | P/E ratio | P/B Ratio | ROE | ROA | ROCE | Upside/Downside | Consensus |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
684 | +1.47% | +0.83% | -3.02% | -5.74% | 14.30x | 6.20x | -75.07% | +1.70% | +19.51% | +66.01% | Strong Buy | ||
65 | +1.40% | +0.98% | +2.96% | +3.50% | 37.30x | 4.36x | -23.19% | +6.62% | +11.51% | +0.63% | Buy | ||
17 | +1.22% | +1.72% | +0.52% | +26.34% | 160.12x | 6.14x | +34.43% | +8.09% | +14.74% | +9.56% | Buy | ||
92 | +1.19% | +0.68% | -3.04% | +1.08% | 53.92x | 2.20x | +11.30% | +2.66% | +4.91% | +29.93% | Strong Buy | ||
12 | +0.50% | +0.79% | +0.65% | +8.15% | 19.09x | 3.01x | +20.01% | +6.11% | +14.13% | +12.50% | Buy | ||
61 | +0.98% | -0.93% | -3.13% | -17.77% | 80.70x | 3.73x | +6.06% | +2.18% | +5.67% | +24.62% | Buy | ||
49 | +1.35% | +0.58% | +5.94% | +18.32% | -4.62x | 4.80x | -90.11% | +6.21% | +13.08% | +8.56% | Buy | ||
156 | +2.48% | +2.79% | +2.77% | -5.73% | 30.11x | 4.10x | +10.54% | +5.36% | +8.07% | +11.83% | Buy | ||
9 | +0.99% | +1.33% | +3.00% | +45.69% | 26.98x | 150.92x | +19.50% | +3.48% | +19.50% | +0.11% | Buy | ||
56 | +1.80% | +1.41% | +5.00% | -1.93% | 53.29x | 3.74x | +11.23% | +7.47% | +10.04% | +12.45% | Buy |